Delivery Order SPE2DB22D2206-SPE2DB25FJK43
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $44,648.74 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $74,758.45 by the Defense Logistics Agency on August 14, 2025, for the supply of Wezlana 90 mg/mL syringes. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 15, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a child delivery order issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $40,654.20 by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025. The contract, awarded without a set-aside designation through competitive procedures, carries a firm fixed price structure with an ultimate completion date of August 8, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $20,895.86 by the Defense Logistics Agency (DLA) Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract employs a firm fixed-price model with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. Performance will occur at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $2,625.38 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $24,121.60 by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed price, non-set-aside contract was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $72,974.58 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $85,972.33 by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,129.52 by the Defense Logistics Agency's Medical Supply Chain on August 2, 2025. This firm fixed-price delivery order, which has an ultimate completion date of August 4, 2025, was competitively awarded with no set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $9,635.30 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is scheduled for completion by July 31, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJK43Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $20,643.53 by the Defense Logistics Agency (DLA) on August 13, 2025, with an ultimate completion date of August 14, 2025. The delivery order, issued under contract 4569085162, is for Wezlana 90 mg/ml syringes and represents a non-set-aside, competitively awarded contract with firm fixed pricing. This award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates its critical role as a major pharmaceutical distributor within the federal medical procurement system, particularly for military and veteran healthcare needs. The company maintains demonstrated capability to fulfill federal procurement requirements through open competition, delivering a diverse range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains. As a prime vendor within the DLA supply chain, AmerisourceBergen supports multiple government healthcare customers, including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key partner in sustaining military medical readiness and global pharmaceutical support operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.6k | 8/13/25 |